Zivo Bioscience, Inc.Zivo Bioscience, Inc.Zivo Bioscience, Inc.

Zivo Bioscience, Inc.

No trades
See on Supercharts
Market capitalization
‪20.55 M‬USD
−4.59USD
‪−7.78 M‬USD
‪27.65 K‬USD
‪1.87 M‬
Beta (1Y)
−0.62

About Zivo Bioscience, Inc.

CEO
John Bernard Payne
Headquarters
Bloomfield Hills
Employees (FY)
8
Founded
1983
FIGI
BBG000BZDWR5
Zivo Bioscience, Inc. engages in the study, development, and commercialization of natural nutritional compounds and bioactive molecules. It offers proprietary algae strain, extracts and supernatants, and bioactive compounds. The company was founded by Howard R. Baer on March 28, 1983 and is headquartered in Bloomfield Hills, MI.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ZIVO is 8.00 USD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Zivo Bioscience, Inc. stocks are traded under the ticker ZIVO.
Zivo Bioscience, Inc. is going to release the next earnings report on May 29, 2024. Keep track of upcoming events with our Earnings Calendar.
ZIVO stock is 9.59% volatile and has beta coefficient of −0.62. Check out the list of the most volatile stocks — is Zivo Bioscience, Inc. there?
ZIVO earnings for the last quarter are −1.05 USD per share, whereas the estimation was −1.05 USD resulting in a 0% surprise. The estimated earnings for the next quarter are −0.91 USD per share. See more details about Zivo Bioscience, Inc. earnings.
Zivo Bioscience, Inc. revenue for the last quarter amounts to ‪12.00 K‬ USD despite the estimated figure of ‪12.00 K‬ USD. In the next quarter revenue is expected to reach ‪18.00 K‬ USD.
Yes, you can track Zivo Bioscience, Inc. financials in yearly and quarterly reports right on TradingView.
ZIVO stock has risen by 11.78% compared to the previous week, the month change is a 3.03% fall, over the last year Zivo Bioscience, Inc. has showed a 54.19% decrease.
ZIVO net income for the last quarter is ‪−1.91 M‬ USD, while the quarter before that showed ‪−1.82 M‬ USD of net income which accounts for −4.58% change. Track more Zivo Bioscience, Inc. financial stats to get the full picture.
Today Zivo Bioscience, Inc. has the market capitalization of ‪20.55 M‬, it has decreased by 7.38% over the last week.
No, ZIVO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ZIVO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Zivo Bioscience, Inc. stock right from TradingView charts — choose your broker and connect to your account.
ZIVO reached its all-time high on Feb 3, 2004 with the price of 3695.26 USD, and its all-time low was 0.48 USD and was reached on Nov 29, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 24, 2024, the company has 8.00 employees. See our rating of the largest employees — is Zivo Bioscience, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Zivo Bioscience, Inc. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Zivo Bioscience, Inc. stock shows the sell signal. See more of Zivo Bioscience, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Zivo Bioscience, Inc. future price: according to them, ZIVO price has a max estimate of 12.00 USD and a min estimate of 12.00 USD. Read a more detailed Zivo Bioscience, Inc. forecast: see what analysts think of Zivo Bioscience, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Zivo Bioscience, Inc. EBITDA is ‪−7.22 M‬ USD, and current EBITDA margin is ‪−26.27 K‬%. See more stats in Zivo Bioscience, Inc. financial statements.